Also, thinking of its wide network in Australia, it is a sweet retail network for foreign acquisition or partnership. Right? The price is good now. I think. Lots of cash. Good profits. Did I miss anything?
- Forums
- ASX - By Stock
- API
- News: API Australian Pharmaceutical Industries Posts FY NPAT Of $56.6 Mln
News: API Australian Pharmaceutical Industries Posts FY NPAT Of $56.6 Mln, page-26
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add API (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online